|
|
cell aggregation
|
GO:0098743 |
1 |
0.998
|
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
3 |
0.992
|
|
|
|
negative regulation of monocyte differentiation
|
GO:0045656 |
3 |
0.988
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.975
|
|
|
|
cartilage condensation
|
GO:0001502 |
1 |
0.966
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
113 |
0.964
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
38 |
0.957
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.952
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.950
|
|
|
|
astrocyte differentiation
|
GO:0048708 |
4 |
0.950
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.949
|
|
|
|
positive regulation of peptidase activity
|
GO:0010952 |
88 |
0.937
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.931
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.923
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
19 |
0.921
|
|
|
|
dna biosynthetic process
|
GO:0071897 |
40 |
0.921
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.919
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.909
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
170 |
0.903
|
|
|
|
positive regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043280 |
69 |
0.902
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.893
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
116 |
0.883
|
|
|
|
negative regulation of astrocyte differentiation
|
GO:0048712 |
1 |
0.880
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.868
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.796
|
|
|
|
regulation of response to dna damage stimulus
|
GO:2001020 |
94 |
0.795
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.794
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.769
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.767
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.756
|
|
|
|
positive regulation of endopeptidase activity
|
GO:0010950 |
84 |
0.751
|
|
|
|
regulation of glomerulus development
|
GO:0090192 |
3 |
0.751
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.746
|
|
|
|
ion homeostasis
|
GO:0050801 |
230 |
0.741
|
|
|
|
system process
|
GO:0003008 |
349 |
0.736
|
|
|
|
regulation of astrocyte differentiation
|
GO:0048710 |
3 |
0.724
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
88 |
0.710
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
6 |
0.702
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.692
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.680
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.661
|
|
|
|
regulation of telomere maintenance
|
GO:0032204 |
13 |
0.660
|
|
|
|
developmental programmed cell death
|
GO:0010623 |
3 |
0.659
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.657
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
156 |
0.644
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
168 |
0.640
|
|
|
|
tube morphogenesis
|
GO:0035239 |
95 |
0.637
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.635
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.626
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.626
|
|
|
|
negative regulation of glial cell differentiation
|
GO:0045686 |
1 |
0.614
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.606
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
213 |
0.603
|
|
|
|
sodium ion transmembrane transport
|
GO:0035725 |
59 |
0.584
|
|
|
|
negative regulation of reactive oxygen species metabolic process
|
GO:2000378 |
11 |
0.570
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.570
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.563
|
|
|
|
positive regulation of mesenchymal cell proliferation
|
GO:0002053 |
2 |
0.539
|
|
|
|
regulation of cell proliferation involved in kidney development
|
GO:1901722 |
3 |
0.535
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.534
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
117 |
0.534
|
|
|
|
response to uv
|
GO:0009411 |
73 |
0.528
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.527
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.520
|
|
|
|
embryonic skeletal system development
|
GO:0048706 |
13 |
0.498
|
|
|
|
bicarbonate transport
|
GO:0015701 |
6 |
0.490
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.477
|
|
|
|
regulation of cyclin dependent protein serine threonine kinase activity
|
GO:0000079 |
36 |
0.475
|
|
|
|
chloride transport
|
GO:0006821 |
41 |
0.470
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.465
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
81 |
0.460
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.456
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.454
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.439
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.435
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.433
|
|
|
|
cellular cation homeostasis
|
GO:0030003 |
163 |
0.433
|
|
|
|
cell cycle g2 m phase transition
|
GO:0044839 |
43 |
0.431
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.427
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.422
|
|
|
|
regulation of dna metabolic process
|
GO:0051052 |
153 |
0.421
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.419
|
|
|
|
regulation of neuronal synaptic plasticity
|
GO:0048168 |
1 |
0.417
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.416
|
|
|
|
regulation of glial cell differentiation
|
GO:0045685 |
3 |
0.413
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.411
|
|
|
|
embryonic appendage morphogenesis
|
GO:0035113 |
9 |
0.409
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
24 |
0.407
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
24 |
0.403
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
61 |
0.402
|
|
|
|
morphogenesis of an epithelium
|
GO:0002009 |
60 |
0.400
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
212 |
0.398
|
|
|
|
embryonic skeletal system morphogenesis
|
GO:0048704 |
9 |
0.394
|
|
|
|
response to growth factor
|
GO:0070848 |
205 |
0.390
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.387
|
|
|
|
iron ion homeostasis
|
GO:0055072 |
15 |
0.383
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.375
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.372
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.371
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.370
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.369
|
|
|
|
epidermis development
|
GO:0008544 |
59 |
0.368
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.367
|
|
|
|
circulatory system development
|
GO:0072359 |
262 |
0.363
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.362
|
|
|
|
male sex differentiation
|
GO:0046661 |
25 |
0.361
|
|
|
|
negative regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process
|
GO:2000059 |
3 |
0.360
|
|
|
|
appendage morphogenesis
|
GO:0035107 |
16 |
0.360
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.356
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.356
|
|
|
|
regulation of glomerular mesangial cell proliferation
|
GO:0072124 |
3 |
0.354
|
|
|
|
regulation of apoptotic process involved in morphogenesis
|
GO:1902337 |
1 |
0.353
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.346
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
140 |
0.344
|
|
|
|
cellular homeostasis
|
GO:0019725 |
196 |
0.337
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.333
|
|
|
|
regulation of translation
|
GO:0006417 |
89 |
0.333
|
|
|
|
response to hyperoxia
|
GO:0055093 |
4 |
0.327
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.323
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
42 |
0.320
|
|
|
|
positive regulation of apoptotic process involved in morphogenesis
|
GO:1902339 |
1 |
0.320
|
|
|
|
bmp signaling pathway
|
GO:0030509 |
49 |
0.320
|
|
|
|
response to gamma radiation
|
GO:0010332 |
14 |
0.313
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.309
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.308
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.304
|
|
|
|
borate transport
|
GO:0046713 |
1 |
0.299
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.299
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.291
|
|
|
|
connective tissue development
|
GO:0061448 |
39 |
0.286
|
|
|
|
negative regulation of protein serine threonine kinase activity
|
GO:0071901 |
57 |
0.283
|
|
|
|
positive regulation of wnt signaling pathway
|
GO:0030177 |
54 |
0.281
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.280
|
|
|
|
embryonic limb morphogenesis
|
GO:0030326 |
9 |
0.280
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.278
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.270
|
|
|
|
regulation of dna biosynthetic process
|
GO:2000278 |
18 |
0.266
|
|
|
|
glomerular mesangial cell proliferation
|
GO:0072110 |
3 |
0.266
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.265
|
|
|
|
inorganic anion transmembrane transport
|
GO:0098661 |
47 |
0.264
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.263
|
|
|
|
positive regulation of myeloid cell apoptotic process
|
GO:0033034 |
2 |
0.263
|
|
|
|
autophagic cell death
|
GO:0048102 |
3 |
0.262
|
|
|
|
response to lipid
|
GO:0033993 |
206 |
0.262
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.252
|
|
|
|
dna replication
|
GO:0006260 |
116 |
0.250
|
|
|
|
limb morphogenesis
|
GO:0035108 |
16 |
0.246
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.243
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.242
|
|
|
|
male gonad development
|
GO:0008584 |
23 |
0.241
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.239
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.238
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.238
|
|
|
|
hemopoiesis
|
GO:0030097 |
180 |
0.238
|
|
|
|
regulation of mesenchymal cell proliferation
|
GO:0010464 |
5 |
0.237
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.234
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.234
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.233
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.233
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.233
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.228
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.227
|
|
|
|
response to cocaine
|
GO:0042220 |
1 |
0.225
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.225
|
|
|
|
response to other organism
|
GO:0051707 |
261 |
0.224
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
146 |
0.223
|
|
|
|
cation homeostasis
|
GO:0055080 |
189 |
0.223
|
|
|
|
embryonic viscerocranium morphogenesis
|
GO:0048703 |
1 |
0.221
|
|
|
|
hematopoietic or lymphoid organ development
|
GO:0048534 |
186 |
0.218
|
|
|
|
positive regulation of fibroblast proliferation
|
GO:0048146 |
21 |
0.211
|
|
|
|
cell proliferation involved in kidney development
|
GO:0072111 |
3 |
0.210
|
|
|
|
regulation of vasculature development
|
GO:1901342 |
97 |
0.210
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.209
|
|
|
|
telomere maintenance
|
GO:0000723 |
32 |
0.208
|
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
39 |
0.207
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.205
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
48 |
0.204
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.203
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
121 |
0.202
|
|
|
|
mitotic g1 s transition checkpoint
|
GO:0044819 |
17 |
0.198
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.197
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.194
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.194
|
|
|
|
blood vessel development
|
GO:0001568 |
172 |
0.193
|
|
|
|
endocrine system development
|
GO:0035270 |
26 |
0.189
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.188
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.188
|
|
|
|
oxidative stress induced premature senescence
|
GO:0090403 |
3 |
0.188
|
|
|
|
development of primary male sexual characteristics
|
GO:0046546 |
23 |
0.185
|
|
|
|
positive regulation of dna metabolic process
|
GO:0051054 |
73 |
0.185
|
|
|
|
proteolysis involved in cellular protein catabolic process
|
GO:0051603 |
244 |
0.185
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.183
|
|
|
|
borate transmembrane transport
|
GO:0035445 |
1 |
0.183
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.182
|
|
|
|
oxidation reduction process
|
GO:0055114 |
396 |
0.181
|
|
|
|
proteasomal protein catabolic process
|
GO:0010498 |
176 |
0.181
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.177
|
|
|
|
embryonic cranial skeleton morphogenesis
|
GO:0048701 |
6 |
0.177
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.176
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.176
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.176
|
|
|
|
epithelial cell migration
|
GO:0010631 |
119 |
0.175
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.174
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.172
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
60 |
0.172
|
|
|
|
gliogenesis
|
GO:0042063 |
21 |
0.171
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
142 |
0.171
|
|
|
|
pericardium development
|
GO:0060039 |
2 |
0.171
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.165
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.164
|
|
|
|
glomerular basement membrane development
|
GO:0032836 |
3 |
0.162
|
|
|
|
negative regulation of fibroblast proliferation
|
GO:0048147 |
12 |
0.162
|
|
|
|
cellular response to gonadotropin stimulus
|
GO:0071371 |
4 |
0.161
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.159
|
|
|
|
mitotic dna integrity checkpoint
|
GO:0044774 |
30 |
0.158
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
79 |
0.158
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
96 |
0.158
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.156
|
|
|
|
monocyte differentiation
|
GO:0030224 |
15 |
0.156
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.155
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.155
|
|
|
|
gland development
|
GO:0048732 |
48 |
0.154
|
|
|
|
positive regulation of response to dna damage stimulus
|
GO:2001022 |
43 |
0.153
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.152
|
|
|
|
lens development in camera type eye
|
GO:0002088 |
2 |
0.151
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.151
|
|
|
|
g2 m transition of mitotic cell cycle
|
GO:0000086 |
41 |
0.150
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.149
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.149
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
4 |
0.149
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
1 |
0.148
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.145
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
91 |
0.143
|
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
12 |
0.143
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.142
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.141
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.140
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
186 |
0.140
|
|
|
|
regulation of cell matrix adhesion
|
GO:0001952 |
42 |
0.138
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.136
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.135
|
|
|
|
embryonic organ development
|
GO:0048568 |
36 |
0.135
|
|
|
|
regulation of protein stability
|
GO:0031647 |
87 |
0.135
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.135
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.135
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
166 |
0.134
|
|
|
|
type b pancreatic cell development
|
GO:0003323 |
4 |
0.134
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.134
|
|
|
|
mapk cascade
|
GO:0000165 |
288 |
0.133
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.132
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.131
|
|
|
|
positive regulation of dna biosynthetic process
|
GO:2000573 |
8 |
0.131
|
|
|
|
double strand break repair
|
GO:0006302 |
101 |
0.131
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.128
|
|
|
|
appendage development
|
GO:0048736 |
23 |
0.126
|
|
|
|
hormone metabolic process
|
GO:0042445 |
61 |
0.126
|
|
|
|
ubiquitin dependent protein catabolic process
|
GO:0006511 |
206 |
0.126
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.126
|
|
|
|
zymogen activation
|
GO:0031638 |
70 |
0.126
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.126
|
|
|
|
endomembrane system organization
|
GO:0010256 |
196 |
0.125
|
|
|
|
respiratory system development
|
GO:0060541 |
22 |
0.125
|
|
|
|
g1 dna damage checkpoint
|
GO:0044783 |
18 |
0.123
|
|
|
|
somatic muscle development
|
GO:0007525 |
1 |
0.122
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.122
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.122
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.121
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.121
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
136 |
0.120
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.120
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.119
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.119
|
|
|
|
cellular transition metal ion homeostasis
|
GO:0046916 |
21 |
0.118
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.117
|
|
|
|
cellular response to drug
|
GO:0035690 |
27 |
0.116
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.116
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.116
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.115
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.114
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.113
|
|
|
|
camera type eye development
|
GO:0043010 |
25 |
0.112
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.111
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.111
|
|
|
|
cartilage development
|
GO:0051216 |
31 |
0.110
|
|
|
|
regulation of monocyte differentiation
|
GO:0045655 |
5 |
0.110
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
7 |
0.109
|
|
|
|
sodium ion transport
|
GO:0006814 |
61 |
0.109
|
|
|
|
metanephric s shaped body morphogenesis
|
GO:0072284 |
4 |
0.108
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
170 |
0.107
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.106
|
|
|
|
negative regulation of kinase activity
|
GO:0033673 |
106 |
0.105
|
|
|
|
vasculature development
|
GO:0001944 |
181 |
0.105
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.105
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.104
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.103
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.102
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.101
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.099
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.099
|
|
|
|
response to steroid hormone
|
GO:0048545 |
80 |
0.098
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.098
|
|
|
|
negative regulation of neurogenesis
|
GO:0050768 |
26 |
0.097
|
|
|
|
growth
|
GO:0040007 |
202 |
0.096
|
|
|
|
multicellular organismal response to stress
|
GO:0033555 |
1 |
0.095
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.095
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.093
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.093
|
|
|
|
positive regulation of insulin like growth factor receptor signaling pathway
|
GO:0043568 |
4 |
0.090
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.090
|
|
|
|
apoptotic process involved in morphogenesis
|
GO:0060561 |
3 |
0.089
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.088
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.088
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.087
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.085
|
|
|
|
anion transmembrane transport
|
GO:0098656 |
76 |
0.085
|
|
|
|
protein stabilization
|
GO:0050821 |
64 |
0.085
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.085
|
|
|
|
regulation of gliogenesis
|
GO:0014013 |
7 |
0.085
|
|
|
|
response to increased oxygen levels
|
GO:0036296 |
4 |
0.085
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.083
|
|
|
|
negative regulation of wnt signaling pathway
|
GO:0030178 |
69 |
0.083
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
98 |
0.082
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.082
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.082
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.082
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.082
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
170 |
0.081
|
|
|
|
endothelial cell migration
|
GO:0043542 |
86 |
0.081
|
|
|
|
intracellular signal transduction involved in g1 dna damage checkpoint
|
GO:1902400 |
10 |
0.080
|
|
|
|
positive regulation of canonical wnt signaling pathway
|
GO:0090263 |
33 |
0.080
|
|
|
|
positive regulation of glomerular mesangial cell proliferation
|
GO:0072126 |
1 |
0.080
|
|
|
|
response to external biotic stimulus
|
GO:0043207 |
261 |
0.079
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.078
|
|
|
|
chordate embryonic development
|
GO:0043009 |
34 |
0.078
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.077
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.077
|
|
|
|
translation
|
GO:0006412 |
132 |
0.077
|
|
|
|
limb development
|
GO:0060173 |
23 |
0.076
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.076
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
125 |
0.074
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.074
|
|
|
|
response to toxic substance
|
GO:0009636 |
37 |
0.074
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.074
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.073
|
|
|
|
glial cell differentiation
|
GO:0010001 |
11 |
0.072
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.072
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.072
|
|
|
|
positive regulation of cell adhesion
|
GO:0045785 |
84 |
0.071
|
|
|
|
response to vitamin d
|
GO:0033280 |
10 |
0.071
|
|
|
|
pattern specification process
|
GO:0007389 |
43 |
0.070
|
|
|
|
single organism nuclear import
|
GO:1902593 |
104 |
0.070
|
|
|
|
cell chemotaxis
|
GO:0060326 |
112 |
0.070
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.070
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
127 |
0.070
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.069
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
180 |
0.069
|
|
|
|
cellular response to nutrient
|
GO:0031670 |
12 |
0.069
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.068
|
|
|
|
positive regulation of synaptic transmission
|
GO:0050806 |
4 |
0.068
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.067
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.067
|
|
|
|
metanephros development
|
GO:0001656 |
16 |
0.067
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.066
|
|
|
|
cellular response to heparin
|
GO:0071504 |
2 |
0.066
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
87 |
0.066
|
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
42 |
0.066
|
|
|
|
heart development
|
GO:0007507 |
95 |
0.066
|
|
|
|
pituitary gland development
|
GO:0021983 |
2 |
0.065
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.065
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
60 |
0.065
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.064
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.064
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
26 |
0.064
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.064
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.064
|
|
|
|
hindlimb morphogenesis
|
GO:0035137 |
2 |
0.064
|
|
|
|
protein import
|
GO:0017038 |
130 |
0.064
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
125 |
0.064
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.064
|
|
|
|
mammary gland epithelium development
|
GO:0061180 |
10 |
0.063
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.063
|
|
|
|
glandular epithelial cell development
|
GO:0002068 |
5 |
0.063
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
136 |
0.063
|
|
|
|
eye development
|
GO:0001654 |
42 |
0.063
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.063
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.063
|
|
|
|
epithelium migration
|
GO:0090132 |
119 |
0.062
|
|
|
|
positive regulation of odontogenesis
|
GO:0042482 |
3 |
0.062
|
|
|
|
sex determination
|
GO:0007530 |
3 |
0.062
|
|
|
|
regulation of metanephros development
|
GO:0072215 |
4 |
0.062
|
|
|
|
negative regulation of cellular senescence
|
GO:2000773 |
5 |
0.061
|
|
|
|
proton transport
|
GO:0015992 |
22 |
0.061
|
|
|
|
cellular component disassembly
|
GO:0022411 |
92 |
0.061
|
|
|
|
response to heparin
|
GO:0071503 |
3 |
0.061
|
|
|
|
ureteric bud development
|
GO:0001657 |
13 |
0.061
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
116 |
0.061
|
|
|
|
negative regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043154 |
46 |
0.061
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.060
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.060
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.060
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
24 |
0.060
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.059
|
|
|
|
chromatin remodeling
|
GO:0006338 |
55 |
0.059
|
|
|
|
metanephros morphogenesis
|
GO:0003338 |
9 |
0.059
|
|
|
|
response to lithium ion
|
GO:0010226 |
2 |
0.058
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.058
|
|
|
|
nuclear import
|
GO:0051170 |
106 |
0.058
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.058
|
|
|
|
pml body organization
|
GO:0030578 |
2 |
0.058
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.058
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.058
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.057
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.057
|
|
|
|
erythrocyte differentiation
|
GO:0030218 |
28 |
0.057
|
|
|
|
negative regulation of heart growth
|
GO:0061117 |
2 |
0.057
|
|
|
|
response to bacterium
|
GO:0009617 |
144 |
0.057
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
97 |
0.057
|
|
|
|
response to hormone
|
GO:0009725 |
175 |
0.056
|
|
|
|
regulation of small gtpase mediated signal transduction
|
GO:0051056 |
156 |
0.056
|
|
|
|
type b pancreatic cell differentiation
|
GO:0003309 |
5 |
0.055
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.055
|
|
|
|
cell substrate adherens junction assembly
|
GO:0007045 |
30 |
0.055
|
|
|
|
organic anion transport
|
GO:0015711 |
103 |
0.055
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.055
|
|
|
|
protein heterotetramerization
|
GO:0051290 |
3 |
0.055
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.055
|
|
|
|
negative regulation of translation
|
GO:0017148 |
37 |
0.055
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
48 |
0.054
|
|
|
|
anion transport
|
GO:0006820 |
161 |
0.054
|
|
|
|
response to electrical stimulus
|
GO:0051602 |
1 |
0.054
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.054
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
82 |
0.054
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.054
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
16 |
0.054
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.053
|
|
|
|
enteroendocrine cell differentiation
|
GO:0035883 |
6 |
0.053
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.053
|
|
|
|
protein import into nucleus
|
GO:0006606 |
104 |
0.053
|
|
|
|
cellular iron ion homeostasis
|
GO:0006879 |
8 |
0.053
|
|
|
|
gonad development
|
GO:0008406 |
34 |
0.053
|
|
|
|
signal transduction involved in mitotic cell cycle checkpoint
|
GO:0072413 |
13 |
0.052
|
|
|
|
negative regulation of protein kinase activity
|
GO:0006469 |
98 |
0.052
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
238 |
0.052
|
|
|
|
positive regulation of sequence specific dna binding transcription factor activity
|
GO:0051091 |
131 |
0.052
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.052
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
2 |
0.052
|
|
|
|
hydrogen transport
|
GO:0006818 |
23 |
0.052
|
|
|
|
sex differentiation
|
GO:0007548 |
45 |
0.052
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
177 |
0.051
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.051
|
|
|
|
cell junction organization
|
GO:0034330 |
79 |
0.051
|
|
|
|
cell activation
|
GO:0001775 |
213 |
0.051
|
|
|
|
response to peptide
|
GO:1901652 |
65 |
0.051
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.051
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.050
|
|
|
|
oocyte maturation
|
GO:0001556 |
1 |
0.050
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
135 |
0.049
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.049
|
|
|
|
cellular response to fibroblast growth factor stimulus
|
GO:0044344 |
39 |
0.049
|
|
|
|
proteasome mediated ubiquitin dependent protein catabolic process
|
GO:0043161 |
156 |
0.049
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
185 |
0.048
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
174 |
0.048
|
|
|
|
kidney development
|
GO:0001822 |
53 |
0.048
|
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
31 |
0.048
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.048
|
|
|
|
positive regulation of cell matrix adhesion
|
GO:0001954 |
23 |
0.048
|
|
|
|
regulation of gtpase activity
|
GO:0043087 |
180 |
0.047
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.047
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.047
|
|
|
|
activation of cysteine type endopeptidase activity
|
GO:0097202 |
57 |
0.047
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
194 |
0.047
|
|
|
|
positive regulation of neuron apoptotic process
|
GO:0043525 |
8 |
0.047
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
7 |
0.047
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.047
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
4 |
0.046
|
|
|
|
meiosis i
|
GO:0007127 |
4 |
0.046
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
89 |
0.046
|
|
|
|
response to carbohydrate
|
GO:0009743 |
21 |
0.046
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.046
|
|
|
|
gtp catabolic process
|
GO:0006184 |
237 |
0.046
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.045
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.045
|
|
|
|
negative regulation of cardiac muscle cell proliferation
|
GO:0060044 |
2 |
0.045
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.045
|
|
|
|
metanephric epithelium development
|
GO:0072207 |
7 |
0.045
|
|
|
|
monovalent inorganic cation transport
|
GO:0015672 |
128 |
0.045
|
|
